ASCO: Takeda and Protagonist release positive Phase III VERIFY …
5 days ago · US drugmaker Protagonist Therapeutics (Nasdaq: PTGX) and Japan’s Takeda Pharma (TYO:4502) announced detailed results from the Phase III, randomized, placebo …
ASCO 2025 Breaking News | Pharmaceutical - The Pharmaletter
May 23, 2025 · Welcome to The Pharma Letter’s real-time coverage of the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30 to June 3 in …
Avidicure looks to redefine immunotherapy at ASCO 2025
5 days ago · With ASCO 2025 drawing towards a close in Chicago, Amsterdam-based biotech Avidicure is entering the spotlight with its first public data on a new class of cancer …
Sanofi and Regeneron weigh mixed trial results for itepekimab
May 30, 2025 · US biotech Regeneron and French drugmaker Sanofi are reviewing next steps for their experimental COPD therapy itepekimab following contrasting outcomes from two Phase …
Sandoz launches first interchangeable denosumab biosimilars in USA
5 days ago · Swiss generic and biosimilar medicines company Sandoz (SWX: SDZ) today announced that Wyost (denosumab) and Jubbonti (denosumab) are available to patients in the …
NewLimit | The Pharmaletter
May 7, 2025 · Founded in 2021 by Coinbase CEO Brian Armstrong, former GV partner Blake Byers, and stem cell researcher Jacob Kimmel, the company focuses on extending human …
BeOne Medicines launches following redomiciliation
May 29, 2025 · Sino-American biotech BeiGene has now effected its previously announced transition, becoming BeOne Medicines (Nasdaq: ONC; HKEX: 06160; SSE: 688235) and …
Reshaping HIV – how the journey from daily pills to long-acting ...
May 23, 2025 · This week, Dr Kimberly Smith, Senior Vice President, Chief Scientific Officer, Head of Research & Development at ViiV Healthcare, provides an Expert View on how, …
FDA pauses Rocket’s Phase II trial of RP-A501 for Danon disease
May 27, 2025 · US late-stage biotech Rocket Pharmaceuticals (Nasdaq: RCKT) saw its shares plummet as much as 64% to $2.25 in pre-market activity today, after it announced an update …
Illuminating lupus: latest pharmacological advancements
May 28, 2025 · Lupus is a rare autoimmune disease characterized by chronic inflammation. It presents in four main forms: systemic lupus erythematosus (SLE), cutaneous lupus …